← All stocks

LifeMD, Inc.

LFMD Net selling
CIK 0000948320 #4064 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$54.16K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$54.16K
1 of 1 sales
Net
−$54.16K
−$54.16K against sales at will

By person

17 insiders · 1 transaction
19.5×

Justin Schreiber holds 19.5 times base salary in stock. $9.75M of shares against $500.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Justin Schreiber last reported holding, valued at $3.61, the price Common Stock was last bought or sold at on the open market here, on 9 Dec 2025.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
FRIEDEMAN JESSICA
Chief Marketing Officer
$54.16K (1)
−$54.16K
205,000
0.4253%
$740.15K
+36.7%
Schreiber Justin
Chairman and CEO
2,700,721
5.60%
$9.75M
−8.5%
Alvarez Nicholas P
Chief Acquisition Officer
605,000
1.26%
$2.18M
+19.8%
Strawn John R Jr
Director
498,001
1.03%
$1.80M
+49.4%
Benathen Marc David
Chief Financial Officer
426,554
0.8850%
$1.54M
+41.0%
Yecies Eric Harold
Chief Legal Officer & GC
405,000
0.8402%
$1.46M
+49.3%
Kavthekar Atul
Chief Financial Officer
337,500
0.7002%
$1.22M
DiTrolio Joseph
Director
308,413
0.6398%
$1.11M
+41.2%
Dray Shayna Webb
Chief Operating Officer
295,000
0.6120%
$1.07M
+37.2%
Simon Roberto
Director
288,175
0.5979%
$1.04M
+140.1%
STAN MARIA E.
Chief Accounting Officer
227,500
0.4720%
$821.39K
+78.4%
Pisano Christopher A
Chief Marketing Officer
200,000
0.4149%
$722.10K
Wijnker Dennis
Chief Technology Officer
175,000
0.3631%
$631.84K
+75.0%
LAROVERE JOAN
Director
142,050
0.2947%
$512.87K
+89.4%
Galluppi Stefan
Chief Innovation Officer
110,449
0.2291%
$398.78K
+143.0%
Sripad Umesh
Chief Technology Officer
75,000
0.1556%
$270.79K
MACRAE CALUM ARCHIBALD
Director
73,865
0.1532%
$266.69K
+347.7%
Insider
Date
Role
Action
Shares
Price
Amount
FRIEDEMAN JESSICA
9 Dec 2025
Chief Marketing Officer
Sell
15,000
$3.61
$54.16K

What was left out

Form 4 filings counted 14
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 999,325
History held since 27 Oct 2017